AU2014320015B2 - Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution - Google Patents

Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution Download PDF

Info

Publication number
AU2014320015B2
AU2014320015B2 AU2014320015A AU2014320015A AU2014320015B2 AU 2014320015 B2 AU2014320015 B2 AU 2014320015B2 AU 2014320015 A AU2014320015 A AU 2014320015A AU 2014320015 A AU2014320015 A AU 2014320015A AU 2014320015 B2 AU2014320015 B2 AU 2014320015B2
Authority
AU
Australia
Prior art keywords
mvp
solution
thr
gly
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014320015A
Other languages
English (en)
Other versions
AU2014320015A1 (en
Inventor
David Cetlin
Arun Dhar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cygnus Technologies LLC
Original Assignee
Cygnus Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Technologies LLC filed Critical Cygnus Technologies LLC
Publication of AU2014320015A1 publication Critical patent/AU2014320015A1/en
Application granted granted Critical
Publication of AU2014320015B2 publication Critical patent/AU2014320015B2/en
Priority to AU2021200484A priority Critical patent/AU2021200484B2/en
Priority to AU2023229501A priority patent/AU2023229501B2/en
Assigned to CYGNUS TECHNOLOGIES, LLC reassignment CYGNUS TECHNOLOGIES, LLC Request for Assignment Assignors: MOCKV SOLUTIONS LLC
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/015—Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2014320015A 2013-09-10 2014-09-09 Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution Active AU2014320015B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2021200484A AU2021200484B2 (en) 2013-09-10 2021-01-27 Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution
AU2023229501A AU2023229501B2 (en) 2013-09-10 2023-09-12 Methods and kits for quantifying the removal of mock virus particles from a purified solution

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361875729P 2013-09-10 2013-09-10
US61/875,729 2013-09-10
PCT/IB2014/064352 WO2015036917A2 (en) 2013-09-10 2014-09-09 Methods and kits for quantifying the removal of mock virus particles from a purified solution

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2021200484A Division AU2021200484B2 (en) 2013-09-10 2021-01-27 Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution

Publications (2)

Publication Number Publication Date
AU2014320015A1 AU2014320015A1 (en) 2016-03-31
AU2014320015B2 true AU2014320015B2 (en) 2020-10-29

Family

ID=52625972

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2014320015A Active AU2014320015B2 (en) 2013-09-10 2014-09-09 Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution
AU2021200484A Active AU2021200484B2 (en) 2013-09-10 2021-01-27 Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution
AU2023229501A Active AU2023229501B2 (en) 2013-09-10 2023-09-12 Methods and kits for quantifying the removal of mock virus particles from a purified solution

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2021200484A Active AU2021200484B2 (en) 2013-09-10 2021-01-27 Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution
AU2023229501A Active AU2023229501B2 (en) 2013-09-10 2023-09-12 Methods and kits for quantifying the removal of mock virus particles from a purified solution

Country Status (7)

Country Link
US (4) US9632087B2 (enExample)
EP (1) EP3044339B1 (enExample)
JP (2) JP6549126B2 (enExample)
CN (1) CN105899684B (enExample)
AU (3) AU2014320015B2 (enExample)
DK (1) DK3044339T3 (enExample)
WO (1) WO2015036917A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3044339T3 (da) * 2013-09-10 2019-08-12 MockV Solutions Fremgangsmåder og sæt til kvantificering af fjernelsen af falske (MOCK) viruspartikler fra en renset opløsning
WO2020100957A1 (ja) * 2018-11-14 2020-05-22 日産化学株式会社 生体材料の保存、前処理、分析のための容器及び方法
JP7390466B2 (ja) * 2020-02-28 2023-12-01 旭化成メディカル株式会社 ウイルスクリアランス性能の評価方法
US12203914B2 (en) 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
CN118465260B (zh) * 2024-07-09 2024-10-15 浙江康佰裕生物科技有限公司 测定逆转录病毒包膜蛋白elisa方法的建立及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814442A (en) * 1994-06-10 1998-09-29 Georgetown University Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
US20100297604A1 (en) * 2006-06-09 2010-11-25 Xing-Xiang Li Methods and reagents for virus isolation and detection

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01503675A (ja) * 1986-09-08 1989-12-14 アプライド・バイオテクノロジー・インコーポレーテツド 中空ウイルスキヤプシドのワクチン
US5173399A (en) * 1988-06-10 1992-12-22 Abbott Laboratories Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
CA2002839C (en) * 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
WO1993000103A1 (en) * 1991-06-21 1993-01-07 The Wistar Institute Of Anatomy And Biology Chimeric envelope proteins for viral targeting
US7122645B2 (en) 2000-03-27 2006-10-17 Smithkline Beecham Corporation Detection of viable agents
EP2365082A1 (en) * 2000-06-27 2011-09-14 Pfizer Animal Health S.A. BVDV virus-like particles
US20040002058A1 (en) * 2001-06-21 2004-01-01 Uab Research Foundation Chimeric capsid proteins and uses thereof
US7041444B2 (en) * 2003-01-14 2006-05-09 Washington University Murine calicivirus
WO2005023313A1 (en) * 2003-09-09 2005-03-17 Virxsys Corporation Lentivirus vector-based approaches for generating an immune response to hiv humans
EP1973608A1 (en) * 2005-12-14 2008-10-01 Cytos Biotechnology AG Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2008036899A2 (en) * 2006-09-22 2008-03-27 Amgen Inc. Methods for removing viral contaminants during protein purification
JP5710254B2 (ja) * 2007-09-14 2015-04-30 アンスティテュ・パストゥールＩｎｓｔｉｔｕｔ Ｐａｓｔｅｕｒ 外来エピトープを含む組換え偽ウイルスの発現および分泌を可能とするポリヌクレオチド、それらの製造および使用
GB0803068D0 (en) * 2008-02-20 2008-03-26 Health Prot Agency Cross-linked biological indicator
NZ592097A (en) * 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
US9744228B2 (en) * 2010-04-07 2017-08-29 Norvartis Ag Method for generating a parvovirus B19 virus-like particle
BR112012026095A2 (pt) * 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
DK3044339T3 (da) * 2013-09-10 2019-08-12 MockV Solutions Fremgangsmåder og sæt til kvantificering af fjernelsen af falske (MOCK) viruspartikler fra en renset opløsning

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814442A (en) * 1994-06-10 1998-09-29 Georgetown University Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
US20100297604A1 (en) * 2006-06-09 2010-11-25 Xing-Xiang Li Methods and reagents for virus isolation and detection

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GRIMM, D. et al, "Titration of AAV-2 Particles via a Novel Capsil ELISA: Packaging of Genomes Can Limit Production of Recombinant AAV-2", GENE THERAPY. 1999, vol. 6, no. 7, pp 1322 - 1330 *
Holger Maerz et al., "Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration", Nature Biotechnology, 1996, vol. 14, pages 651-652 *
KUCK, D. et al, "Development of AAV serotype-specific ELISAs using novel monoclonal antibodies", JOURNAL OF VIROLOGICAL METHODS, 2007, vol. 140, no. 1-2, pp 17 - 24 *
WISTUBA A. et al., "Subcellular compartmentalization of adeno-associated virus type 2 assembly", JOURNAL OF VIROLOGY.1997, vol. 71, no. 2, pp 1341 - 1352 *

Also Published As

Publication number Publication date
EP3044339A2 (en) 2016-07-20
US20190353656A1 (en) 2019-11-21
US20150072339A1 (en) 2015-03-12
EP3044339B1 (en) 2019-05-22
WO2015036917A2 (en) 2015-03-19
CN105899684B (zh) 2021-06-11
AU2014320015A1 (en) 2016-03-31
CN105899684A (zh) 2016-08-24
US11754565B2 (en) 2023-09-12
US10309963B2 (en) 2019-06-04
AU2023229501A1 (en) 2023-09-28
EP3044339A4 (en) 2017-04-26
AU2021200484B2 (en) 2023-06-29
AU2023229501B2 (en) 2025-04-03
WO2015036917A3 (en) 2015-12-03
JP2016529908A (ja) 2016-09-29
US9632087B2 (en) 2017-04-25
JP2019195333A (ja) 2019-11-14
US20240085419A1 (en) 2024-03-14
JP6549126B2 (ja) 2019-07-31
AU2021200484A1 (en) 2021-02-25
US20170192001A1 (en) 2017-07-06
DK3044339T3 (da) 2019-08-12

Similar Documents

Publication Publication Date Title
AU2021200484B2 (en) Methods and kits for quantifying the removal of Mock Virus Particles from a purified solution
Van Der Loo et al. Progress and challenges in viral vector manufacturing
EP2154147B1 (en) A truncated l1 protein of human papillomavirus 16
CN106479985A (zh) 病毒介导的Cpf1蛋白在CRISPR/Cpf1基因编辑系统中的应用
TWI735433B (zh) 偵測生物污染物之組成物及方法
CN115141258A (zh) 预测祖先病毒序列的方法及其用途
CN109069616A (zh) 稳定化的可溶性融合前rsv f蛋白
CN112724208A (zh) 一种SADS-CoV重组S蛋白胞外段及其制备方法与应用
CN105859877A (zh) 一种hpv特异性抗体的制备方法及冻干制剂
CN111729078B (zh) 鸡传染性贫血病毒基因工程疫苗
RU2445357C1 (ru) Рекомбинантный штамм дрожжей pichia angusta - продуцент капсидного белка l1 вируса папилломы человека типа 16
CN110724695A (zh) 一种编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
CN120518721B (zh) 一种巨细胞病毒糖蛋白b及其制备方法和应用
EP3250696B1 (en) Stock solution of retrovirus like particles with method
RU2445358C1 (ru) Рекомбинантный штамм дрожжей pichia angusta - продуцент капсидного белка l1 вируса папилломы человека типа 18
CN119842809A (zh) 一种hpv中和抗体假病毒及其制备方法和应用
CN120683135A (zh) 嵌合表达新冠病毒rbd蛋白的甲型流感病毒样颗粒及其制备方法和应用
HK40006673A (en) Methods of predicting ancestral virus sequences and uses thereof
HK40006673B (en) Methods of predicting ancestral virus sequences and uses thereof
GP120 Patent reports
Affinity Tagging Retrovirus Vectors with a Metal

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PATENTEE NAME TO READ MOCKV SOLUTIONS LLC

PC Assignment registered

Owner name: CYGNUS TECHNOLOGIES, LLC

Free format text: FORMER OWNER(S): MOCKV SOLUTIONS LLC